Skip to content
biorxiv.org· Grabinski, N. S., Reardon, J. J., Shah, S., Adorno, J. J., Lee, P., Packard, R. L., Ramamoorthy, Y., Thies, K. A., Chakravarthy, P. A., Agarwal, S. S., Spehar, J. M., Arsiwala, T. A., Carpenter, J. W., Mossing, A. A., Schiebel, J. G., Steck, S. A., Didier, A. J., Richardson, D. S., Kollin, L., Venere, M., Godbout, J. P., Lockman, P. R., Beyer, S., Corps, K. N., Winter, J. O., Song, J. W., Sizemore, S. T., Sizemore, G. M. ·· 21 hours agoScore48

Breast Cancer-derived PDGFB Remodels the CNS Vascular Niche to Promote Brain, Spinal and Leptomeningeal Metastasis

Breast Cancer-derived PDGFB Remodels the CNS Vascular Niche to Promote Brain, Spinal and Leptomeningeal Metastasis

In brief

Breast cancer-derived PDGFB remodels the CNS vascular niche to promote metastasis to the brain, spinal cord and leptomeninges. In triple-negative breast cancer models, PDGFB enhanced human brain microvascular endothelial cell sprouting, increased permeability in 3D blood-brain barrier models and disrupted tight junction proteins, with permeability changes seen in both PDGFR-beta-positive and PDGFR-beta-negative endothelial systems. In vivo, PDGFB raised CNS metastatic burden and drove spinal and leptomeningeal colonization, and patient transcriptomic datasets showed angiogenesis pathway enrichment in PDGFB-high tumors from patients with CNS metastases.

Source: biorxiv.org · biorxiv.org

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org